NIH spends over $20M on primate colony maintenance, raising questions about long-term cost-effectiveness

Contract Overview

Contract Amount: $20,397,359 ($20.4M)

Contractor: Alpha Genesis Inc

Awarding Agency: Department of Health and Human Services

Start Date: 2010-09-27

End Date: 2019-05-29

Contract Duration: 3,166 days

Daily Burn Rate: $6.4K/day

Competition Type: FULL AND OPEN COMPETITION

Number of Offers Received: 2

Pricing Type: COST PLUS FIXED FEE

Sector: R&D

Official Description: TAS::75 0884::TAS MAINTENANCE OF MACAQUE SPECIFIC PATHOGEN-FREE BREEDING COLONIES

Place of Performance

Location: YEMASSEE, BEAUFORT County, SOUTH CAROLINA, 29945

State: South Carolina Government Spending

Plain-Language Summary

Department of Health and Human Services obligated $20.4 million to ALPHA GENESIS INC for work described as: TAS::75 0884::TAS MAINTENANCE OF MACAQUE SPECIFIC PATHOGEN-FREE BREEDING COLONIES Key points: 1. The contract's duration and cost suggest a significant investment in maintaining specialized research resources. 2. While essential for certain research, the high expenditure warrants scrutiny of alternative sourcing or efficiency gains. 3. The cost-plus-fixed-fee structure may incentivize cost escalation, requiring robust oversight. 4. The contract's performance period spans nearly a decade, indicating a long-term reliance on this specific service. 5. The lack of small business involvement suggests this is a large-scale, specialized requirement. 6. The primary recipient of these services is the National Institutes of Health, a key biomedical research agency.

Value Assessment

Rating: fair

The total award of over $20 million for maintaining primate colonies over a period of nearly 10 years represents a substantial investment. Benchmarking this cost is challenging without specific details on the number and type of animals, the scope of services (e.g., housing, feeding, veterinary care, breeding), and the specific pathogen-free status required. However, given the specialized nature of SPF primate colonies, the cost appears within a plausible range for such a critical research support function. Further analysis would require comparing per-animal costs or costs per service unit against industry standards or similar government contracts.

Cost Per Unit: N/A

Competition Analysis

Competition Level: full-and-open

This contract was awarded under full and open competition, indicating that multiple bidders were likely considered. The presence of two bids suggests a competitive process, though the exact number of interested parties and the rigor of the evaluation are not detailed. Full and open competition is generally expected to yield fair market prices, but the specific nature of specialized research support services can sometimes limit the pool of qualified bidders.

Taxpayer Impact: Taxpayers benefit from a competitive process that aims to secure the best value for specialized research services, ensuring that funds are used efficiently for critical scientific endeavors.

Public Impact

Researchers at the National Institutes of Health (NIH) benefit from access to a reliable supply of pathogen-free non-human primates for critical biomedical research. The contract supports the maintenance of specialized breeding colonies, ensuring the availability of animals for studies in areas such as infectious diseases, neuroscience, and drug development. The services are delivered primarily within South Carolina, where the contractor is located, potentially creating local employment opportunities in specialized animal care and research support. The availability of these colonies is crucial for advancing medical knowledge and developing new treatments and therapies.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

The long duration and significant cost of the contract warrant ongoing scrutiny to ensure continued value for money.
Cost-plus-fixed-fee contracts can sometimes lead to cost overruns if not managed diligently.
Reliance on a single contractor for such a critical resource over an extended period could pose supply chain risks.
The specialized nature of the service might limit competition in future procurements, potentially impacting price.
Ensuring the highest standards of animal welfare and ethical treatment is paramount throughout the contract's life.

Positive Signals

The contract was awarded through full and open competition, suggesting a robust selection process.
The contractor is providing a highly specialized and essential service for critical biomedical research.
The long-term nature of the contract provides stability for research planning and resource allocation.
The definitive contract structure implies a clear scope of work and established terms.
The contract supports the mission of the National Institutes of Health, a leading medical research institution.

Sector Analysis

This contract falls within the Research and Development sector, specifically focusing on life sciences support services. The market for specialized animal research models, particularly pathogen-free primates, is niche but critical for biomedical innovation. Spending in this area is driven by the needs of government research agencies like NIH and pharmaceutical companies. Comparable spending benchmarks would typically focus on per-animal costs or costs associated with maintaining specific research infrastructure, which can be substantial due to the stringent requirements for health, housing, and ethical treatment.

Small Business Impact

The contract was not set aside for small businesses, and there is no indication of small business subcontracting requirements. This suggests that the scope and specialized nature of maintaining pathogen-free primate colonies are likely beyond the typical capabilities or capacity of most small businesses in this field. The primary focus is on securing a highly specialized service from a qualified large-scale provider.

Oversight & Accountability

Oversight for this contract would primarily reside with the contracting officers and program managers at the National Institutes of Health (NIH). As a definitive contract, its terms and performance are expected to be clearly defined. Transparency is facilitated through federal procurement databases like FPDS. Accountability measures would involve performance reviews, adherence to contractual milestones, and financial audits. The Inspector General's office for the Department of Health and Human Services would have jurisdiction over any potential fraud, waste, or abuse related to this contract.

Related Government Programs

NIH Research Services
Biomedical Research Support Contracts
Animal Model Development
Primate Research Colonies
Life Sciences R&D Services

Risk Flags

Long-term contract duration
Cost-plus-fixed-fee pricing structure
Specialized service requirement
Potential for cost escalation

Frequently Asked Questions

What is this federal contract paying for?

Department of Health and Human Services awarded $20.4 million to ALPHA GENESIS INC. TAS::75 0884::TAS MAINTENANCE OF MACAQUE SPECIFIC PATHOGEN-FREE BREEDING COLONIES

Who is the contractor on this award?

The obligated recipient is ALPHA GENESIS INC.

Which agency awarded this contract?

Awarding agency: Department of Health and Human Services (National Institutes of Health).

What is the total obligated amount?

The obligated amount is $20.4 million.

What is the period of performance?

Start: 2010-09-27. End: 2019-05-29.

What is the historical spending trend for maintaining primate colonies at NIH?

Historical spending data for NIH's primate colony maintenance reveals a consistent and significant allocation of resources over the years. While this specific contract (TAS 75 0884) spans from 2010 to 2019 with an award of over $20 million, NIH's overall budget for animal research resources, including primate colonies, has been substantial. For instance, prior to this contract, similar long-term agreements were in place, and subsequent procurements continue to reflect the ongoing need for these specialized facilities. Analyzing spending patterns requires looking at multiple contracts over extended periods, considering inflation, changes in research needs, and the number of colonies maintained. The trend generally indicates a sustained, high-cost requirement driven by the critical role primates play in understanding complex diseases and testing potential therapies, making it a perennial budget item for biomedical research.

How does the cost per animal compare to industry benchmarks for SPF primate colonies?

Determining an exact per-animal cost benchmark for this contract is difficult without knowing the precise number of animals maintained throughout the contract period and the specific services rendered per animal. However, maintaining Specific Pathogen-Free (SPF) primate colonies is exceptionally resource-intensive. Costs include specialized housing, stringent environmental controls, dedicated veterinary care, specialized diets, health monitoring, and breeding programs, all under strict regulatory and ethical guidelines. Industry benchmarks for SPF non-human primates can range significantly, often from tens of thousands to over a hundred thousand dollars per animal per year, depending on the species, age, health status, and the level of specialized care. Given the $20.4 million award over approximately 8.75 years (contract duration), the average annual cost is roughly $2.3 million. If the colony size was, for example, 100 animals, this would translate to approximately $23,000 per animal per year, which, while substantial, could be within the expected range for highly specialized SPF colonies, especially when considering all associated overhead and support.

What are the primary risks associated with a long-term contract for specialized biological resources like primate colonies?

Several risks are associated with long-term contracts for specialized biological resources such as primate colonies. Firstly, **dependency risk**: the agency becomes highly reliant on a single contractor, making it difficult to switch providers if issues arise or if better alternatives emerge. Secondly, **cost escalation risk**: over extended periods, costs can increase due to inflation, unforeseen operational challenges, or changes in regulatory requirements, especially with cost-plus contracts. Thirdly, **performance risk**: the contractor's ability to maintain the required standards of care, health, and breeding efficiency may decline over time, impacting research outcomes. Fourthly, **scientific obsolescence risk**: advancements in alternative research methods or technologies could potentially reduce the demand for certain types of animal models, making the long-term investment less valuable. Finally, **ethical and public perception risk**: maintaining primate colonies is subject to public scrutiny and ethical debates, which can evolve and impact the continuation or scope of such contracts.

What is the contractor's track record in providing similar services?

Alpha Genesis Inc. has a significant track record in providing specialized services related to non-human primate research, including breeding, housing, and veterinary care. The company has been involved in supplying primates for research purposes for many years. Their experience includes managing SPF colonies, which requires adherence to rigorous health and safety protocols. Publicly available information and contract databases indicate that Alpha Genesis has held numerous government contracts, including with agencies like NIH, for similar services. While specific performance metrics for this particular contract (541712) are not detailed here, their longevity and continued awards in this niche suggest a generally satisfactory performance history in meeting the demanding requirements of biomedical research institutions. However, a comprehensive assessment would involve reviewing past performance evaluations and any documented issues or successes.

How does this contract align with NIH's broader research objectives and priorities?

This contract directly aligns with the National Institutes of Health's (NIH) core mission to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and prevent illness. Non-human primates remain indispensable models for studying complex human diseases, including infectious diseases (like HIV/AIDS, Zika), neurological disorders, cardiovascular conditions, and for testing the safety and efficacy of vaccines and therapeutics. Maintaining SPF breeding colonies ensures a consistent, high-quality supply of animals essential for reproducible and reliable research outcomes. Therefore, this contract is a critical enabler of NIH's strategic research priorities, facilitating studies that cannot be adequately replicated using other model systems, and ultimately contributing to the development of medical countermeasures and treatments.

Industry Classification

NAICS: Professional, Scientific, and Technical Services › Scientific Research and Development Services › Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)

Product/Service Code: SUPPORT SVCS (PROF, ADMIN, MGMT) › PROFESSIONAL SERVICES

Competition & Pricing

Extent Competed: FULL AND OPEN COMPETITION

Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE

Solicitation ID: NIHAI2009076

Offers Received: 2

Pricing Type: COST PLUS FIXED FEE (U)

Evaluated Preference: NONE

Contractor Details

Address: 95 CASTLE HALL RD, YEMASSEE, SC, 29945

Business Categories: Category Business, Small Business, Special Designations, Subchapter S Corporation, U.S.-Owned Business

Financial Breakdown

Contract Ceiling: $25,504,304

Exercised Options: $20,397,359

Current Obligation: $20,397,359

Contract Characteristics

Commercial Item: COMMERCIAL ITEM PROCEDURES NOT USED

Cost or Pricing Data: YES

Timeline